Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery

Documenti analoghi

• Identification of 2‐Substituted‐3‐Hydroxy‐2,3‐Dihydroquinazolin‐4(1 H ) Ones as Cell‐Active Inhibitors of KDM4A Lysine Demethylase
  di: Alessandra Feoli, et al.
  Pubblicazione: (2026)
• Design, Synthesis, and Biological Evaluation of Novel Triazine‐Based Dual Histone Deacetylase/phosphatidylinositol 3‐kinase Inhibitors for Breast Cancer Therapy
  di: Lara Luzietti, et al.
  Pubblicazione: (2026)
• A Novel Synthetic Route for Lysine‐Specific Demethylase 1‐Targeting Compounds: CC‐90011 and MS9117
  di: Jingying Wang, et al.
  Pubblicazione: (2026)
• Nonsteroidal Anti‐Inflammatory Drugs as Modulators of Cation Channels: Fenamates Repurposing in Channelopathies
  di: Paola Laghetti, et al.
  Pubblicazione: (2025)
• Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors
  di: Jochem Nelen, et al.
  Pubblicazione: (2026)